RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. WARF Ventures
W

WARF Ventures portfolio

WARF Ventures has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $95M.
Latest deal: Elephas Biosciences · Nov 6, 2025.
About this page

Its most recent investment on record is Elephas Biosciences's $40M Series B+ round in November 2025, alongside Moore Strategic Ventures, ARCH Venture Partners, Sands Capital Ventures and 2 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with Sands Capital Ventures, Moore Strategic Ventures and ARCH Venture Partners, most often Sands Capital Ventures (2 rounds).

What WARF Ventures invests in

WARF Ventures recent investments

How WARF Ventures invests

StageDealsCapital in rounds
Series B+ 2 67%$95M
Seed 1 33%undisclosed
YearDealsCapital in rounds
2021 1 33%undisclosed
2024 1 33%$55M
2025 1 33%$40M

WARF Ventures portfolio companies

CompanyRound with WARF VenturesTotal raisedLatest raise
EElephas Biosciences
Health and bio
Series B+ · $40M$95MNov 6, 2025
Series B+
LLynx Biosciences
Health and bio
SeedundisclosedFeb 7, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name WARF Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists WARF Ventures, which is a subset of its real portfolio. API: /api/v1/investors/warf-ventures (get a free API key). More: the most active VC firms and new venture capital funds.